Overweight, not just obesity, drives higher healthcare costs, Norwegian study finds

A study at NTNU shows that while individual healthcare costs are highest for obese individuals, the overall societal costs are greater for the larger number of overweight people, highlighting the need for population-level health measures.

FDA rejects Melinta, Venatorx’s UTI antibiotic over CMC issues

The FDA handed a CRL to Melinta Therapeutics and Venatorx Pharmaceuticals for their urinary tract infection antibiotic, with the agency calling for more information on

February 24, 2024

MYK-224 by Bristol-Myers Squibb for Diastolic Heart Failure (HFpEF): Likelihood of Approval

Share this article GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug

February 16, 2024

FDA challenges safety, efficacy of Geron’s imetelstat ahead of advisory committee meeting

The FDA said Tuesday that it is unconvinced the benefits of Geron’s imetelstat outweigh the risks in certain anemic myelodysplastic syndrome (MDS) patients who are

March 13, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.